Civic Intelligence

Global Genomic Medicine Collaborative

990 • Fiscal year 2017 • EIN 81-3079744

Jan 01, 2017 to Dec 31, 2017

Durham, NC
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • NTEE E • <$500k nonprofits • Source year 2017

Liabilities / Revenue

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • NTEE E • <$500k nonprofits • Source year 2017

Net Margin

90th percentile

51%

Higher net margin than 90% of similar nonprofits.

2017 filings • NTEE E • <$500k nonprofits • Source year 2017

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2017

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Assets

$223,693

No earlier filing loaded for comparison.

Net Assets

$223,693

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$220,000

No earlier filing loaded for comparison.

Expenses

$108,174

No earlier filing loaded for comparison.

Net Income

$111,826

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2017: $223,693Liabilities 2017: $0Net Assets 2017: $223,6932017Assets 2018: $490,073Liabilities 2018: $597Net Assets 2018: $489,4762018Assets 2019: $421,478Liabilities 2019: $9,363Net Assets 2019: $412,1152019Assets 2020: $633,214Liabilities 2020: $1,453Net Assets 2020: $631,7612020Assets 2021: $1,365,095Liabilities 2021: $1,516Net Assets 2021: $1,363,5792021Assets 2022: $1,234,362Liabilities 2022: $875Net Assets 2022: $1,233,4872022Assets 2023: $279,746Liabilities 2023: $2,985Net Assets 2023: $276,7612023Assets 2024: $285,845Liabilities 2024: $2,324Net Assets 2024: $283,5212024

Highlighted filing

2017

Assets$223,693
Liabilities$0
Net Assets$223,693

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$2.0M$1.0M$0-$1.0MRevenue 2017: $220,000Expenses 2017: $108,174Net Income 2017: $111,8262017Revenue 2018: $608,798Expenses 2018: $343,015Net Income 2018: $265,7832018Revenue 2019: $329,000Expenses 2019: $406,361Net Income 2019: -$77,3612019Revenue 2020: $917,522Expenses 2020: $697,876Net Income 2020: $219,6462020Revenue 2021: $1,687,021Expenses 2021: $955,203Net Income 2021: $731,8182021Revenue 2022: $952,070Expenses 2022: $1,082,162Net Income 2022: -$130,0922022Revenue 2023: $226,540Expenses 2023: $1,183,266Net Income 2023: -$956,7262023Revenue 2024: $666,860Expenses 2024: $670,403Net Income 2024: -$3,5432024

Highlighted filing

2017

Revenue$220,000
Expenses$108,174
Net Income$111,826
Filing Detail Status

This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview

Mission

The entity is organized and operated exclusively for charitable and educational purposes within the meaning of section 501(c)(3) of the internal revenue code to include advancing genomic medicine in clinical care through global collaborations.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings